Swine flu drug may be ‘no better than aspirin’
Pharmaceutical companies should make full data from their clinical trials publicly available so the risks and benefits of the drugs can be independently analysed, researchers say.
The researchers have documented a number of cases in which access to full trial data “radically changed public knowled…
To read the full story on your mobile please use this link
To read the full story on a PC or Mac please use this link